Literature DB >> 11535724

Time course evaluation of myocardial perfusion after reperfusion therapy by 99mTc-tetrofosmin SPECT in patients with acute myocardial infarction.

R Tanaka1, T Nakamura.   

Abstract

UNLABELLED: Myocardial perfusion imaging with 99mTc-labeled agents immediately after reperfusion therapy can underestimate myocardial salvage. It is also conceivable that delayed imaging is useful for assessing the risk area. However, to our knowledge, very few studies have sequentially evaluated these image changes. We conducted 99mTc-tetrofosmin (TF) and 123I-beta-methyl-p-iodophenylpentadecanoic acid (BMIPP) SPECT before and after reperfusion to treat acute myocardial infarction and quantified changes in TF myocardial accumulation and reverse redistribution.
METHODS: Seventeen patients with a first myocardial infarction underwent successful reperfusion. We examined SPECT images obtained at the onset (preimage), those acquired 30 min (early image) and 6 h (delayed image) after TF injection, and images acquired 1, 4, 7, and 20 d after reperfusion (post-1-d, post-4-d, post-7-d, and post-20-d image, respectively). We also examined BMIPP SPECT images after 7 +/- 1.8 d (BMIPP image). Polar maps were divided into 48 segments to calculate percentage uptake, and time course changes in segment numbers below 60% were observed as abnormal area. Moreover, cardiac function was analyzed by gated TF SPECT on 1 and 20 d after reperfusion.
RESULTS: In reference to the abnormal area on the early images, the post-1-d image was significantly improved compared with the preimage (P < 0.01) as was the post-7-d image compared with the post-1-d and post-4-d images (P < 0.05, respectively). However, post-20-d and post-7-d images did not significantly differ. Therefore, the improvement in myocardial accumulation reached a plateau 7 d after reperfusion. On the other hand, the abnormal area on the delayed images was significantly greater (P < 0.01) compared with that on the early images from 4 to 20 d after reperfusion, as the value was essentially constant. The correlations of the abnormal area between the preimage and the post-7-d delayed image, the preimage and the BMIPP image, and the post-7-d delayed image and the BMIPP image were very close (r = 0.963, r = 0.981, and r = 0.975, respectively). Gated TF SPECT revealed that the left ventricular ejection fraction was not significantly different (P = not significant) between 1 and 20 d after reperfusion, but regional wall motion was significantly different after reperfusion (P < 0.05).
CONCLUSION: These results suggest that the interval between reperfusion therapy and TF SPECT should be 7 d to evaluate the salvage effect and that TF delayed and BMIPP images are both useful in estimation of risk area.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11535724

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  9 in total

Review 1.  The Japanese experience with metabolic imaging in the clinical setting.

Authors:  Nagara Tamaki; Koichi Morita; Yuko Kawai
Journal:  J Nucl Cardiol       Date:  2007 May-Jun       Impact factor: 5.952

Review 2.  Delayed recovery of fatty acid metabolism after transient myocardial ischemia: a potential imaging target for "ischemic memory".

Authors:  Steven A Messina; Omer Aras; Vasken Dilsizian
Journal:  Curr Cardiol Rep       Date:  2007-04       Impact factor: 2.931

3.  Comparative assessment of 18F-fluorodeoxyglucose PET and 99mTc-tetrofosmin SPECT for the prediction of functional recovery in patients with reperfused acute myocardial infarction.

Authors:  Haruhisa Shirasaki; Akira Nakano; Hiroyasu Uzui; Yoshiharu Yonekura; Hidehiko Okazawa; Takanori Ueda; Jong-Dae Lee
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-04-04       Impact factor: 9.236

4.  Incremental predictive value of myocardial scintigraphy with 123I-BMIPP in patients with acute myocardial infarction treated with primary percutaneous coronary intervention.

Authors:  Mamoru Nanasato; Haruo Hirayama; Akitada Ando; Satoshi Isobe; Makoto Nonokawa; Yoshimi Kinoshita; Ichiro Nanbu; Mitsuhiro Yokota; Toyoaki Murohara
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-07-01       Impact factor: 9.236

5.  Enhanced washout of 99mTc-tetrofosmin in hypertrophic cardiomyopathy: quantitative comparisons with regional 123I-BMIPP uptake and wall thickness determined by MRI.

Authors:  Tohoru Takeda; Jin Wu; Yuko Fumikura; Keiji Iida; Satoru Kawano; Iwao Yamaguchi; Yuji Itai
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-05-20       Impact factor: 9.236

6.  Nitrate-enhanced gated SPECT in patients with primary angioplasty for acute myocardial infarction: evidence of a reversible and nitrate-sensitive impairment of myocardial perfusion.

Authors:  Wassila Djaballah; Marc A Muller; Michael Angioï; Frédéric Moulin; Andrei Codreanu; Damien Mandry; Gérard Ethevenot; Gilles Karcher; Etienne Aliot; Pierre Y Marie
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-07-31       Impact factor: 9.236

7.  Discrepancy between myocardial perfusion and fatty acid metabolism following acute myocardial infarction for evaluating the dysfunctional viable myocardium.

Authors:  Shankar K Biswas; Masayoshi Sarai; Hiroshi Toyama; Hitoshi Hishida; Yukio Ozaki
Journal:  Indian Heart J       Date:  2012-03-26

8.  Myocardial salvage after ST-segment-elevation myocardial infarction: comparison between prasugrel and clopidogrel in the presence or absence of high-residual platelet reactivity.

Authors:  Ruka Yoshida; Kensuke Takagi; Hideki Ishii; Itsuro Morishima; Akihito Tanaka; Yasuhiro Morita; Yasunori Kanzaki; Hiroaki Nagai; Naoki Watanabe; Koichi Furui; Naoki Shibata; Naoki Yoshioka; Ryota Yamauchi; Shotaro Komeyama; Hiroki Sugiyama; Hideyuki Tsuboi; Toyoaki Murohara
Journal:  J Nucl Cardiol       Date:  2019-08-19       Impact factor: 5.952

9.  Radionuclide imaging of jeopardized myocardium: From the beginning of the race to the finish line.

Authors:  Valeria Gaudieri; Carmela Nappi; Mario Petretta
Journal:  J Nucl Cardiol       Date:  2019-09-23       Impact factor: 5.952

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.